Massachusetts H2503 mandates training for employees on recognizing and responding to severe allergic reactions using epinephrine auto-injectors.
Massachusetts H2503 aims to reduce risks associated with allergic reactions by requiring businesses and entities to train their employees on recognizing and responding to severe allergic reactions using epinephrine auto-injectors. The training must be conducted by a licensed physician, nurse practitioner, or an approved organization. The bill also allows for remote authorization by a physician or nurse practitioner for administering epinephrine auto-injectors. Businesses and entities that comply with these provisions may be recognized through a certification program.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.